These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35390709)

  • 1. Injectable adhesive hemostatic gel with tumor acidity neutralizer and neutrophil extracellular traps lyase for enhancing adoptive NK cell therapy prevents post-resection recurrence of hepatocellular carcinoma.
    Cheng Y; Gong Y; Chen X; Zhang Q; Zhang X; He Y; Pan L; Ni B; Yang F; Xu Y; Zhou L; Yang Y; Chen W
    Biomaterials; 2022 May; 284():121506. PubMed ID: 35390709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Injectable Epigenetic Autophagic Modulatory Hydrogel for Boosting Umbilical Cord Blood NK Cell Therapy Prevents Postsurgical Relapse of Triple-Negative Breast Cancer.
    Gong Y; Chen W; Chen X; He Y; Jiang H; Zhang X; Pan L; Ni B; Yang F; Xu Y; Zhang Q; Zhou L; Cheng Y
    Adv Sci (Weinh); 2022 Aug; 9(23):e2201271. PubMed ID: 35712750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogel Crosslinked with Nanoparticles for Prevention of Surgical Hemorrhage and Recurrence of Hepatocellular Carcinoma.
    Zhu JQ; Wu H; Li X; Li MY; Li ZL; Xu XF; Gu LH; Yin DX; Shen F; Huang DS; Yang T
    Adv Sci (Weinh); 2024 Mar; 11(9):e2305508. PubMed ID: 38145957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral Lactate Depletion Based on Injectable Nanoparticles-Hydrogel Composite System Synergizes with Immunotherapy against Postablative Hepatocellular Carcinoma Recurrence.
    Chen Y; Bei J; Chen M; Cai W; Zhou Z; Cai M; Huang W; Lin L; Guo Y; Liu M; Huang X; Xiao Z; Xu Z; Zhu K
    Adv Healthc Mater; 2024 Mar; 13(6):e2303031. PubMed ID: 37848188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased neutrophil extracellular traps promote metastasis potential of hepatocellular carcinoma via provoking tumorous inflammatory response.
    Yang LY; Luo Q; Lu L; Zhu WW; Sun HT; Wei R; Lin ZF; Wang XY; Wang CQ; Lu M; Jia HL; Chen JH; Zhang JB; Qin LX
    J Hematol Oncol; 2020 Jan; 13(1):3. PubMed ID: 31907001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An injectable hydrogel to disrupt neutrophil extracellular traps for treating rheumatoid arthritis.
    Wang N; Ma J; Song W; Zhao C
    Drug Deliv; 2023 Dec; 30(1):2173332. PubMed ID: 36724178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil extracellular traps regulating tumorimmunity in hepatocellular carcinoma.
    Zhu W; Fan C; Dong S; Li X; Chen H; Zhou W
    Front Immunol; 2023; 14():1253964. PubMed ID: 38173719
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Yan X; Sun T; Song Y; Peng W; Xu Y; Luo G; Li M; Chen S; Fang WW; Dong L; Xuan S; He T; Cao B; Lu Y
    Nano Lett; 2022 Mar; 22(6):2251-2260. PubMed ID: 35254836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy.
    Qu J; Zhao X; Ma PX; Guo B
    Acta Biomater; 2017 Aug; 58():168-180. PubMed ID: 28583902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil extracellular traps and complications of liver transplantation.
    Liu Y; Yan P; Bin Y; Qin X; Wu Z
    Front Immunol; 2022; 13():1054753. PubMed ID: 36466888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil extracellular traps induce tumor metastasis through dual effects on cancer and endothelial cells.
    Jiang ZZ; Peng ZP; Liu XC; Guo HF; Zhou MM; Jiang D; Ning WR; Huang YF; Zheng L; Wu Y
    Oncoimmunology; 2022; 11(1):2052418. PubMed ID: 35309732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wrecking neutrophil extracellular traps and antagonizing cancer-associated neurotransmitters by interpenetrating network hydrogels prevent postsurgical cancer relapse and metastases.
    Zhou H; Zhu C; Zhao Q; Ni J; Zhang H; Yang G; Ge J; Fang C; Wei H; Zhou X; Zhang K
    Bioact Mater; 2024 Sep; 39():14-24. PubMed ID: 38783926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An injectable and tumor-specific responsive hydrogel with tissue-adhesive and nanomedicine-releasing abilities for precise locoregional chemotherapy.
    Wu D; Shi X; Zhao F; Chilengue STF; Deng L; Dong A; Kong D; Wang W; Zhang J
    Acta Biomater; 2019 Sep; 96():123-136. PubMed ID: 31247382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injectable Hydrogels Including Magnetic Nanosheets for Multidisciplinary Treatment of Hepatocellular Carcinoma via Magnetic Hyperthermia.
    Gong J; Hu J; Yan X; Xiang L; Chen S; Yang H; Chen Z; Hou Q; Song Y; Xu Y; Liu D; Ji C; Qin Q; Sun H; Peng J; Cao B; Lu Y
    Small; 2024 Jan; 20(3):e2300733. PubMed ID: 37452437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Neutrophil Extracellular Traps: A Novel Antitumor Strategy.
    Zuo H; Yang M; Ji Q; Fu S; Pu X; Zhang X; Wang X
    J Immunol Res; 2023; 2023():5599660. PubMed ID: 38023616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer.
    Zecca A; Barili V; Olivani A; Biasini E; Boni C; Fisicaro P; Montali I; Tiezzi C; Dalla Valle R; Ferrari C; Cariani E; Missale G
    Front Immunol; 2022; 13():875072. PubMed ID: 35677052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Navoximod modulates local HSV-1 replication to reshape tumor immune microenvironment for enhanced immunotherapy via an injectable hydrogel.
    Zhuang Q; Zhao B; Lin Z; Liang Y; Zhao Q; Wang Y; Liao N; Tu H; Zheng Y; Chen H; Zeng Y; Zhang D; Liu X
    Commun Biol; 2023 Jun; 6(1):621. PubMed ID: 37296221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injectable magnetic montmorillonite colloidal gel for the postoperative treatment of hepatocellular carcinoma.
    Chen S; Song Y; Yan X; Dong L; Xu Y; Xuan S; Shu Q; Cao B; Hu J; Xing H; Wu W; Zha Z; Lu Y
    J Nanobiotechnology; 2022 Aug; 20(1):381. PubMed ID: 35986283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications.
    Sung PS; Jang JW
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
    Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
    Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.